Overview
Hetrombopag is under investigation in clinical trial NCT03976882 (Hetrombopag for the Treatment of Chemotherapy-induced Thrombocytopenia in Subjects With Malignancy.).
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/06/04 | N/A | ENROLLING_BY_INVITATION | Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | ||
2025/02/11 | Not Applicable | Recruiting | Beijing Children's Hospital | ||
2024/08/20 | Phase 4 | Recruiting | The Third People's Hospital of Chengdu | ||
2024/06/27 | Phase 2 | Recruiting | |||
2024/05/30 | Phase 2 | Recruiting | |||
2023/10/25 | Phase 2 | Not yet recruiting | |||
2023/09/14 | Phase 2 | Not yet recruiting | |||
2023/08/01 | Phase 2 | Not yet recruiting | Sun Yat-sen University | ||
2023/07/13 | Phase 2 | Not yet recruiting | |||
2023/07/13 | Phase 2 | Recruiting | Shandong University |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.